治疗长期意识障碍的阿波摩尔芬:多式联络式开放标签研究
Leandro R D Sanz1,2,3, Nicolas Lejeune1,2,4,5, Emilie Szymkowicz1,2
1Coma Science Group, GIGA Consciousness, University of Liège, Liège, Belgium.
EClinicalMedicine
|December 3, 2024
概括
在患有长期意识障碍 (PDoC) 的患者中,阿波莫芬治疗显著改善了意识. 这项研究显示大脑连接和新陈代谢的增强,这表明阿波莫尔芬是PDoC的潜在治疗方法.
科学领域:
- 神经科学是一个神经科学.
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 长时间的意识障碍 (PDoC) 在神经康复中存在重大挑战.
- 作为多巴胺作用剂的阿波莫尔芬正在被研究,因为它有可能改善PDoC的恢复.
- 之前的研究显示了行为改善,但疗效和神经机制需要进一步调查.
研究的目的:
- 研究阿波莫尔芬在PDoC患者中的疗效和神经机制.
- 评估在阿波莫芬治疗后的行为和神经生理变化.
- 评估阿波莫尔芬治疗在严重脑损伤的人群中的安全性和可行性.
主要方法:
- 一项开放标签,受控研究,涉及13名PDoC患者超过30天.
- 治疗阿波摩芬组 (n=6) 接受皮下注射,而对照组 (n=7) 接受标准护理.
- 多模式结局措施包括昏迷恢复尺度修订 (CRS-R),脑电图 (EEG) 和氧糖正子发射断层扫描 (FDG-PET).
主要成果:
- 与对照组和基线相比,阿波莫尔芬治疗显著改善了行为诊断 (CRS-R).
- 接受阿波莫芬治疗的患者表现出增加的意识行为,改善大脑连接 (α频段) 和增强全脑新陈代谢.
- 阿波莫尔芬治疗与家庭和医务人员报告的更高的DoC感觉得分有关.
结论:
- 阿波莫尔芬治疗导致PDoC患者意识的长期改善.
- 观察到的大脑连接和新陈代谢的变化为神经生理机制提供了洞察力.
- 阿波莫尔芬是PDoC的可行和安全的治疗选择,需要进一步的临床研究.
相关概念视频
Stages of General Anesthesia
369
Various sedation levels offer significant advantages in facilitating procedural interventions for patients undergoing medical or invasive surgical procedures. These levels span from anxiolysis to general anesthesia, providing a spectrum of sedative effects to cater to specific patient needs. Anxiolysis reduces anxiety and is achieved through minimal sedation, enabling patients to remain awake and responsive while feeling more at ease during the procedure. This level can benefit minor...
369
Opioid Analgesics: Synthetic and Semisynthetic Opioids
223
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
223
Parenteral Anesthetics: Overview
100
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
100
Depolarizing Blockers: Pharmocokinetics
305
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
305
Sedatives and Hypnotics Drugs: Miscellaneous Agents
146
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
146
CNS Depressants: Barbiturates and Benzodiazepines
224
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
224


